Lifeboat Foundation

This year’s ceremony was held virtually (thanks, coronavirus), but the fun remained.

“Planet Earth Report” provides descriptive links to headline news by leading science journalists about the extraordinary discoveries, technology, people, and events changing our knowledge of Planet Earth and the future of the human species.

The Universe Might Be Too Thin, Scientists may have found a new crack in our understanding of the universe, reports The Atlantic and Quanta. The cosmos is starting to look a bit weird. For a few years now, cosmologists have been troubled by a discrepancy in how fast the universe is expanding. They know how fast it should be going, based on ancient light from the early universe, but apparently the modern universe has picked up too much speed—a clue that scientists might have overlooked one of the universe’s fundamental ingredients, or some aspect of how those ingredients stir together.

The biotech company Moderna released a 135-page document on Thursday that spells out the details of how it is conducting the late-stage trial of its coronavirus vaccine.

The company hopes to earn the trust of the public and of scientists who have clamored for details of its study.

The disease is caused by a bacteria that commonly infects livestock.

A new study suggests anticholinergic medications may increase the risk of accelerated cognitive decline, especially in older adults at high risk of developing Alzheimer’s disease.

Anticholinergic drugs block the action of acetylcholine, a chemical messenger that controls a range of automatic bodily functions and plays a vital role in memory and attention.

Doctors prescribe these drugs for a variety of conditions, including urinary incontinence, overactive bladder, chronic obstructive pulmonary disorder (COPD), seasonal allergies, and depression.

About 25% of all patents filed by projects supported by Horizon 2020 have come from ERC projects, even though commercialization of research is not the agency’s main aim. Bourguignon and his colleagues rightly argue that many advances in fundamental research ultimately contribute to innovation and benefit society. But that is a hard message to get across at a time of constrained funding and competing priorities.

Europe’s flagship science agency will be crucial to a post-coronavirus world. Slashing its budget will be a senseless act.

A single infusion of an experimental drug markedly reduced levels of the coronavirus in newly infected patients and lowered the chances that they would need hospitalization, the drug’s maker announced on Wednesday.

The drug is a monoclonal antibody, a manufactured copy of an antibody produced by a patient who recovered from Covid-19, the illness caused by the coronavirus. Many scientists hope that monoclonal antibodies will prove to be powerful treatments for Covid-19, but they are difficult and expensive to manufacture, and progress has been slow.

A so-called monoclonal antibody lowered levels of the coronavirus and prevented hospitalizations. The research has not yet been vetted by independent experts.

What if you could touch a loved one during a video call—particularly in today’s social distancing era of COVID-19—or pick up and handle a virtual tool in a video game?

Pending user tests and funding to commercialize the new technology, these ideas could become reality in a couple of years after UNSW Sydney engineers developed a new haptic device which recreates the sense of touch.

Haptic technology mimics the experience of touch by stimulating localized areas of the skin in ways that are similar to what is felt in the real world, through force, vibration or motion.

Although the SARS-CoV-2 virus has sickened more than 14 million people, bats contract similar viruses all the time without experiencing any known symptoms. Now, the newly sequenced genomes of six species spanning the bat family tree reveal how they’ve been outsmarting viruses for 65 million years. The findings are an “excellent starting point for understanding the superstar immune systems of bats,” says Laurel Yohe, a postdoc at Yale University who studies bat evolution and was not involved with the work. With more than 1400 species, bats are the second most diverse group of mammals on Earth. They live on every continent except Antarctica, and range in size from two to more than 1000 grams. They fly, they echolocate, and some live up to 41 years—a long time for animals of their size. They are also known to carry many different kinds of viruses, including coronaviruses, with no ill effects.

Newly sequenced genomes reveal the secrets of their “superstar” immune systems.